Veterinary News and Research

RSS

Epithelial cells in breast milk can help assess breast cancer risk

Breast cancer risk can be assessed by examining the epithelial cells found in breast milk, according to preliminary study results presented at the AACR 102nd Annual Meeting 2011, held April 2-6.

4 Apr 2011

Study: Thyroid hormone deficiency can affect cone opsins and colour vision

Thyroid hormone controls the eye's visual pigments throughout life. What part does the thyroid gland have in vision? Thyroid hormone is crucially involved in controlling which visual pigment is produced in the cones. Previously, it was assumed that the colour sensitivity of the cones is fixed in the adult retina.

30 Mar 2011

Study finds malaria as a serious problem for patients with landmine injuries

Malaria can complicate the course of disease in poor farmers with landmine injuries in underdeveloped countries, where both malaria and war injuries are frequent causes of illness and death. Tove Heger's doctoral research has charted the extent and effect of malaria on war-injured people and studied the potential for preventing them contracting the disease.

25 Mar 2011

Xirrus deploys high performance Wi-Fi Arrays at EMA

Xirrus, the only Wi-Fi Power Play in the industry, announced today the deployment of Xirrus high performance Wi-Fi Arrays at the European Medicines Agency.

24 Mar 2011

New report shows 2% decrease in anxiolytic and hypnotic sales in Norway

After many years of gradual increase followed by a three-year levelling off period, sales of addictive anxiolytic and hypnotic drugs decreased by just under two per cent in 2010.

24 Mar 2011

UDL enters license agreement with Humeca for burn, wound care products

Mylan Inc. today announced that its subsidiary UDL Laboratories, part of the Mylan Institutional business, has entered a license agreement with Humeca, a leading plastic surgery and burn treatment products company, for the exclusive U.S. distribution rights of Humeca products.

23 Mar 2011

Decades-old FDA approved hypertension drug may delay onset and reduce severity of MS

People suffering from multiple sclerosis may benefit if patent-pending research conducted at Purdue University shows that a decades-old drug approved by the FDA to treat hypertension also delays the onset and reduces the severity of MS symptoms.

16 Mar 2011

Dog owners more physically active: proven many times over now

There is enough scientific evidence now to show that dogs can be powerful motivators to get people moving. Dog owners are more likely to take regular walks and new research has shown that dog walkers are more active overall than people who don’t have dogs. One of the studies showed that older people are more likely to take regular walks if the walking companion is canine rather than human.

14 Mar 2011

'Cross-talk' between two major biological pathways may hold a clue for chronic pain treatment

Researchers at the University of California, Davis have discovered a "cross-talk" between two major biological pathways that involve pain-research that may pave the way to new approaches to understanding and controlling chronic pain.

9 Mar 2011

ADAM-12 gene can serve as treatment target for cancer, arthritis, cardiac hypertrophy

ADAM-12 is not only the name of a 1970's television police drama - it's also the gene that University of Missouri researchers believe could be an important element in the fight against cancer, arthritis, and cardiac hypertrophy, or thickening of the heart's walls.

9 Mar 2011

Study: Role of air pollutants in cardiometabolic syndrome

To explore one of the most critical health/environment intersections - how the very air we breathe can cause heart disease and diabetes and contribute to the problems of obesity - Michigan State University has been named a Clean Air Research Center by the Environmental Protection Agency.

8 Mar 2011

NanoLogix announces MRSA testing preliminary results, new Science Advisory Board members at UTHSC

NanoLogix, a biotechnology innovator in the rapid detection and identification of live-cell microorganisms, announces preliminary results of MRSA testing at the University of Texas Health Science Center - Houston. Dr. Jonathan Faro, M.D., Ph.D. has found NanoLogix technology is able to deliver results for MRSA in 6 hours, as opposed to conventional culture-based testing wait times of 24 to 48 hours.

7 Mar 2011

BioAlliance Pharma awarded €2 million in funding to study Lauriad mucoadhesive technology

BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, today announced the award of €2 million in funding over 30 months from the « Fond Unique Interministériel » (a French program supporting collaborative research projects) including an amount of €743,000 specifically allocated to BioAlliance Pharma.

5 Mar 2011

Researchers demonstrate potential neurochemical mechanism of weight loss

An interdisciplinary group of researchers at the University of Pennsylvania has, for the first time, identified the neurological and cellular signaling mechanisms that contribute to satiety - the sensation of feeling full - and the subsequent body-weight loss produced by drugs used to treat type 2 diabetes. More comprehensive knowledge of these mechanisms could form the basis for anti-obesity medications.

4 Mar 2011

dicomPACS®DX-R 2.0 sets new standards in image processing

OR Technology will present a new version of its X-ray acquisition software at this year’s ECR (European Congress of Radiology) in Vienna. dicomPACS®DX-R version 2.0 provides extended image processing – Cognition Optimised Processing. New adjustment options such as automatic pixel correction reduce image interference and improve the overall impression of the image. Optimal contrast regulation covering the entire image ensures improved recognition of details in soft tissue and bones.

3 Mar 2011

Heterotaxin useful for studying intestinal birth defects may also inhibit cancerous tumor growth

In an interesting bit of scientific serendipity, researchers at North Carolina State University have found that a chemical compound useful for studying the origins of intestinal birth defects may also inhibit the growth and spread of cancerous tumors.

1 Mar 2011

New research reveals how maternal antibodies block immune response to measles virus

New research that reveals how maternal antibodies block an immune response to the measles virus is a first step toward improving current childhood vaccination practices, scientists say.

1 Mar 2011

Cummings School granted U.S. Patent for antibody-based treatment against Hemolytic Uremic Syndrome

Researchers at the Cummings School of Veterinary Medicine have received U.S. patent approval for an antibody-based treatment for Hemolytic Uremic Syndrome (HUS), a potentially fatal outcome of E. coli poisoning and the leading cause of kidney failure in children.

1 Mar 2011

Protein pathway may hold a clue for understanding Parkinson's disease

A protein pathway that may hold the secret to understanding Parkinson's disease has been discovered and explained by Iowa State University researchers.

1 Mar 2011

New horse stem cell discovery aids in preclinical model development for human degenerative diseases

In a world first, pluripotent stem cells have been generated from horses by a team of researchers led by Dr. Andras Nagy at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital and Dr. Lawrence Smith at the University of Montreal's Faculty of Veterinary Science.

28 Feb 2011

Veterinary News and Research

Epithelial cells in breast milk can help assess breast cancer risk

Study: Thyroid hormone deficiency can affect cone opsins and colour vision

Study finds malaria as a serious problem for patients with landmine injuries

Xirrus deploys high performance Wi-Fi Arrays at EMA

New report shows 2% decrease in anxiolytic and hypnotic sales in Norway

UDL enters license agreement with Humeca for burn, wound care products

Decades-old FDA approved hypertension drug may delay onset and reduce severity of MS

Dog owners more physically active: proven many times over now

'Cross-talk' between two major biological pathways may hold a clue for chronic pain treatment

ADAM-12 gene can serve as treatment target for cancer, arthritis, cardiac hypertrophy

Study: Role of air pollutants in cardiometabolic syndrome

NanoLogix announces MRSA testing preliminary results, new Science Advisory Board members at UTHSC

BioAlliance Pharma awarded €2 million in funding to study Lauriad mucoadhesive technology

Researchers demonstrate potential neurochemical mechanism of weight loss

dicomPACS®DX-R 2.0 sets new standards in image processing

Heterotaxin useful for studying intestinal birth defects may also inhibit cancerous tumor growth

New research reveals how maternal antibodies block immune response to measles virus

Cummings School granted U.S. Patent for antibody-based treatment against Hemolytic Uremic Syndrome

Protein pathway may hold a clue for understanding Parkinson's disease

New horse stem cell discovery aids in preclinical model development for human degenerative diseases

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News